Chemours Announces Second Quarter Dividend

RECYCLEXPERT FZE Strengthens Leadership in Data Destruction UAE and GCC with Certified Secure ITAD Services

Flex LNG - 2026 AGM Results Notification

Nona Biosciences Evolves Brand to Reflect Next Phase of Growth in Biotherapeutic Innovation

GLOB Investors Have Opportunity to Lead Globant S.A. Securities Fraud Lawsuit

STRADVISION Observes Growing Demand for Globally Scalable and Production-Ready ADAS Solutions at Auto China 2026

Fermi Responds to Former CEO's Attempts to Take Control of Board and Reverse Board Actions Taken in Accordance with Their Fiduciary Duties to Remove Him as CEO and Terminate Him for Cause

Chattanooga State and Tennessee American Water Host Hamilton County Students in 2026 Elementary Science Olympiad

Rare Shades 7 presentado por 000 Media agrega un estudio de los autos deportivos Porsche en colores inusuales en un lugar extraordinario durante el Festival NYCxDESIGN

Praecipio Receives Atlassian Partner of the Year 2026 for Service Solutions

Solaris Selects Ballard's FCmove®‑SC Engine to Power its Next‑Generation Hydrogen Bus Platform

MingMed Biotechnology présente des données positives de phase II sur le QA102 oral pour le traitement de la dégénérescence maculaire liée à l'âge (DMLA) intermédiaire lors de la réunion 2026 de l'Association for Research in Vision and Ophthalmology (ARVO)

MingMed Biotechnology presenta datos positivos de QA102 oral para la degeneración macular asociada a la edad

MingMed Biotechnology präsentiert auf der Tagung der Association for Research in Vision and Ophthalmology (ARVO) 2026 positive Phase-II-Daten zum oralen Wirkstoff QA102 für die Behandlung der intermediären altersbedingten Makuladegeneration (AMD)

MingMed Biotechnology Presents Positive Phase II Data of Oral QA102 for the Treatment of Intermediate Age-Related Macular Degeneration (AMD) at Association for Research in Vision and Ophthalmology (ARVO) 2026

Greenberg Traurig Secures Appellate Victory for Texas Radiologist in California Income Tax Dispute

Ascletis to Present Data on Multiple Programs at the 33rd European Congress on Obesity (ECO 2026)

KEITYN RECEIVES ASCAP LATIN SONGWRITER OF THE YEAR AWARD; ROMEO SANTOS IS NAMED ASCAP LATIN SONGWRITER/ARTIST OF THE YEAR

Citius Oncology, Inc. Secures Up to $36.5 Million in Debt and Equity Capital to Accelerate LYMPHIR® Commercialization

Quantinuum Announces Pricing of Upsized Initial Public Offering

Suncadia Debuts Suncadia Social with a Three-Day Grand Opening Celebration, June 19-21

POET Deadline: POET Investors with Losses in Excess of $100K Have Opportunity to Lead POET Technologies Inc. Securities Fraud Lawsuit Filed by The Rosen Law Firm

Bell Announces Results of its Cash Tender Offers for Six Series of Debt Securities

HELE Investors Have Opportunity to Lead Helen of Troy Limited Securities Fraud Lawsuit

Rosen Law Firm Encourages Barclays PLC Investors to Inquire About Securities Class Action Investigation - BCS

BMI Investor Alert: Robbins LLP Reminds Investors of the Class Action Lawsuit Against Badger Meter, Inc.

HELE Investor Alert: Robbins LLP Reminds Investors of the Class Action Lawsuit Against Helen of Troy Limited

Bluerock Private Real Estate Fund Set to Pay Increased Distribution for June 2026, Marking Fourth Distribution Increase Since Listing

/C O R R E C T I O N -- Tessitura/

SRAD INVESTOR ALERT: Sportradar Group AG Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit